Pérez de Llano, Luis A <br/><br/>
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.  [electronic resource] 

 -  The journal of allergy and clinical immunology. In practice   
 - 2277-2283.e2 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-2201 
<br/><br/><label>Standard No.: </label>10.1016/j.jaip.2019.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Asthmatic Agents--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Asthma--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Omalizumab--therapeutic use<br/>Pilot Projects<br/>Treatment Outcome